Weining Health (300253): Strong profit growth rate, WINEX and WINGPT accelerate implementation
Weining Health (300253): The 24Q1 profit growth rate is impressive, and strengthening repayment efforts has begun to bear fruit
Weining Health (300253): “1+X” Strategy Deepens Performance Trends for the Better
Southwest Securities released a research report on April 26 stating that it gave Weining Health (300253.SZ) a purchase rating, and the target price was 9.20 yuan. The main reasons for the rating include: 1) steady growth in healthcare informatization reve
Weining Health (300253): WINEX large-scale delivery period has begun to accelerate profit restoration
Weining Health (300253): Profit recovery clearly accelerates implementation of “1+X”
China Galaxy released a research report on April 22 stating that it maintains the Weining Health (300253.SZ) recommendation rating. The main reasons for the rating include: 1) the medical and health information technology business is growing steadily, and
Weining Health (300253): Healthcare IT revenue rises steadily, innovative business losses narrow
Guolian Securities released a research report on April 20 stating that it gave Weining Health (300253.SZ) an increase in holdings rating, and the target price was 7.26 yuan. The main reasons for the rating include: 1) the increase in the revenue share of
Weining Health (300253): Profit recovery is expected to benefit from the promotion of next-generation WINEX and WINGPT
Weining Health (300253): Outstanding performance growth in 23 years, entering the WINEX batch delivery stage in 24
Weining Health (300253) Company Report: AIGC+SAAS, the leader in medical informatization, begins a new journey
Weining Health (300253): Soft service business grows steadily, innovative business starts to improve efficiency
Weining Health (300253) 2023 Third Quarter Report Review: 23Q3 profit recovery is better, actively embracing AI is worth looking forward to
Weining Health (300253): Profits Exceed Expectations AI+ Healthcare Model WINGPT Officially Released
Weining Health (300253): High profit growth in Q3, promising prospects for AI empowerment
Weining Health (300253): Major multi-product launches to actively embrace the AI wave
Weining Health (300253): Medical IT Continues to Grow, Major Medical Models and Applications Officially Released
Weining Health (300253) 2023 semi-annual report review: Short-term performance is under pressure, the medical IT market is gradually picking up
Weining Health (300253): Q2 revenue growth accelerates WINGPT will help upgrade products
No Data